StockNews.com started coverage on shares of Marchex (NASDAQ:MCHX - Free Report) in a report released on Tuesday. The firm issued a hold rating on the technology company's stock.
Marchex Price Performance
Shares of Marchex stock traded up $0.10 during trading hours on Tuesday, hitting $1.86. The company's stock had a trading volume of 30,170 shares, compared to its average volume of 42,943. The company has a market capitalization of $81.25 million, a PE ratio of -20.50 and a beta of 1.87. The stock has a 50 day moving average of $1.97 and a 200 day moving average of $1.89. Marchex has a 12 month low of $1.20 and a 12 month high of $2.40.
Marchex (NASDAQ:MCHX - Get Free Report) last posted its earnings results on Thursday, March 6th. The technology company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.02). Marchex had a negative return on equity of 10.76% and a negative net margin of 8.60%. The business had revenue of $11.92 million for the quarter, compared to the consensus estimate of $12.01 million. Equities analysts expect that Marchex will post -0.1 EPS for the current year.
Hedge Funds Weigh In On Marchex
Large investors have recently added to or reduced their stakes in the company. Arcadia Wealth Management Inc. acquired a new position in shares of Marchex during the fourth quarter worth about $51,000. Millennium Management LLC boosted its position in Marchex by 55.5% during the 4th quarter. Millennium Management LLC now owns 21,287 shares of the technology company's stock worth $37,000 after acquiring an additional 7,598 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Marchex by 3.5% during the 4th quarter. Geode Capital Management LLC now owns 359,641 shares of the technology company's stock worth $630,000 after acquiring an additional 12,255 shares in the last quarter. LPL Financial LLC acquired a new stake in shares of Marchex in the fourth quarter valued at approximately $55,000. Finally, AMH Equity Ltd bought a new stake in shares of Marchex in the fourth quarter worth $438,000. Institutional investors own 73.46% of the company's stock.
About Marchex
(
Get Free Report)
Marchex, Inc, a conversation intelligence company, provides conversational analytics and related solutions in the United States, Canada, and internationally. Its products include Marketing Edge that identifies which campaigns and channels are driving inbound conversations, evaluates what happens during those conversations, and closes the sales loop by connecting converted sales to marketing driven leads; Sonar Business Text Messaging, an artificial intelligence (AI) empowered intelligent workflow enabled mobile messaging solution that enables operations, sales, and marketing teams to communicate personally with field staff, prospects, and customers; Marchex Platform Services, a robust API-based conversation intelligence product that allows executives, sales, customer engagement, and marketing teams to apply Marchex AI to most any calls, regardless of communication platform, in order to identify actionable insights from conversations with their customers; Spotlight, an AI conversation analytics product for multi-location businesses; and Engage, a solution that provides locations with applications to enhance their overall performance.
Further Reading
Before you consider Marchex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.
While Marchex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.